CompanyHealthcare Diagnostics
PreDxion Bio
PreDxion Bio develops rapid, saliva-based antigen tests for SARS-CoV-2, leveraging advanced semiconductor processes for scalable diagnostics. Their technology also monitors immune responses in critically-ill patients.
MicrofluidicsNanosensorsCOVID-19